Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes

Obesity is an established risk factor for breast cancer in post-menopausal women, being associated with elevated serum levels of leptin. Although overweight is a common condition in cat, the role of leptin and its receptor in feline mammary carcinoma remains unsettled. In this study, serum leptin an...

Full description

Bibliographic Details
Main Authors: Andreia Gameiro, Catarina Nascimento, Ana Catarina Urbano, Jorge Correia, Fernando Ferreira
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2021.625147/full
_version_ 1818344189024272384
author Andreia Gameiro
Catarina Nascimento
Ana Catarina Urbano
Jorge Correia
Fernando Ferreira
author_facet Andreia Gameiro
Catarina Nascimento
Ana Catarina Urbano
Jorge Correia
Fernando Ferreira
author_sort Andreia Gameiro
collection DOAJ
description Obesity is an established risk factor for breast cancer in post-menopausal women, being associated with elevated serum levels of leptin. Although overweight is a common condition in cat, the role of leptin and its receptor in feline mammary carcinoma remains unsettled. In this study, serum leptin and leptin receptor (ObR) levels were investigated in 58 cats with mammary carcinoma and compared with those of healthy animals, as were the expression levels of leptin and ObR in tumor tissues. The results showed that the Free Leptin Index is significantly decreased in cats with mammary carcinoma (p = 0.0006), particularly in those with luminal B and HER2-positive tumors, and that these animals also present significantly lower serum leptin levels (p < 0.0001 and p < 0.005, respectively). Interestingly, ulcerating tumors (p = 0.0005) and shorter disease-free survival (p = 0.0217) were associated to serum leptin levels above 4.17 pg/mL. In contrast, elevated serum ObR levels were found in all cats with mammary carcinoma (p < 0.0001), with levels above 16.89 ng/mL being associated with smaller tumors (p = 0.0118), estrogen receptor negative status (p = 0.0291) and increased serum levels of CTLA-4 (p = 0.0056), TNF-α (p = 0.0025), PD-1 (p = 0.0023), and PD-L1 (p = 0.0002). In tumor samples, leptin is overexpressed in luminal B and triple-negative carcinomas (p = 0.0046), whereas ObR is found to be overexpressed in luminal B tumors (p = 0.0425). Altogether, our results support the hypothesis that serum levels of leptin and ObR can be used as biomarkers of specific feline mammary carcinoma subtypes, and suggests the use of leptin antagonists as a therapeutic tool, reinforcing the utility of the cat as a cancer model.
first_indexed 2024-12-13T16:42:31Z
format Article
id doaj.art-d6d3158360904b919e823d8de1da36a1
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-12-13T16:42:31Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-d6d3158360904b919e823d8de1da36a12022-12-21T23:38:15ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692021-02-01810.3389/fvets.2021.625147625147Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma SubtypesAndreia GameiroCatarina NascimentoAna Catarina UrbanoJorge CorreiaFernando FerreiraObesity is an established risk factor for breast cancer in post-menopausal women, being associated with elevated serum levels of leptin. Although overweight is a common condition in cat, the role of leptin and its receptor in feline mammary carcinoma remains unsettled. In this study, serum leptin and leptin receptor (ObR) levels were investigated in 58 cats with mammary carcinoma and compared with those of healthy animals, as were the expression levels of leptin and ObR in tumor tissues. The results showed that the Free Leptin Index is significantly decreased in cats with mammary carcinoma (p = 0.0006), particularly in those with luminal B and HER2-positive tumors, and that these animals also present significantly lower serum leptin levels (p < 0.0001 and p < 0.005, respectively). Interestingly, ulcerating tumors (p = 0.0005) and shorter disease-free survival (p = 0.0217) were associated to serum leptin levels above 4.17 pg/mL. In contrast, elevated serum ObR levels were found in all cats with mammary carcinoma (p < 0.0001), with levels above 16.89 ng/mL being associated with smaller tumors (p = 0.0118), estrogen receptor negative status (p = 0.0291) and increased serum levels of CTLA-4 (p = 0.0056), TNF-α (p = 0.0025), PD-1 (p = 0.0023), and PD-L1 (p = 0.0002). In tumor samples, leptin is overexpressed in luminal B and triple-negative carcinomas (p = 0.0046), whereas ObR is found to be overexpressed in luminal B tumors (p = 0.0425). Altogether, our results support the hypothesis that serum levels of leptin and ObR can be used as biomarkers of specific feline mammary carcinoma subtypes, and suggests the use of leptin antagonists as a therapeutic tool, reinforcing the utility of the cat as a cancer model.https://www.frontiersin.org/articles/10.3389/fvets.2021.625147/fullfeline mammary carcinomaleptinleptin receptorfree leptin indexbiomarkers
spellingShingle Andreia Gameiro
Catarina Nascimento
Ana Catarina Urbano
Jorge Correia
Fernando Ferreira
Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
Frontiers in Veterinary Science
feline mammary carcinoma
leptin
leptin receptor
free leptin index
biomarkers
title Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
title_full Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
title_fullStr Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
title_full_unstemmed Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
title_short Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes
title_sort serum and tissue expression levels of leptin and leptin receptor are putative markers of specific feline mammary carcinoma subtypes
topic feline mammary carcinoma
leptin
leptin receptor
free leptin index
biomarkers
url https://www.frontiersin.org/articles/10.3389/fvets.2021.625147/full
work_keys_str_mv AT andreiagameiro serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes
AT catarinanascimento serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes
AT anacatarinaurbano serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes
AT jorgecorreia serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes
AT fernandoferreira serumandtissueexpressionlevelsofleptinandleptinreceptorareputativemarkersofspecificfelinemammarycarcinomasubtypes